Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
NKTR
$46.75
-0.52%
NKTR
· Nektar Therapeutics
$46.75
-0.24 (-0.52%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$1.95B
Shares
34.14M
Volume · Oct 2
73.04K
Avg daily vol (3M)
998.4K
All webcasts
Earnings call · FY2022 Q4
Nektar Therapeutics (NKTR) Q4 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$22.02M
-11.9% YoY
Net income · derived Q4
-$59.69M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 9, 2023 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 28, 2023 · complete as-filed document